HETERO DRUGS LIMITED
Patent Owner
Stats
- 12 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Apr 13, 2017 most recent publication
Details
- 12 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 205 Total Citation Count
- Mar 03, 2003 Earliest Filing
- 78 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8669265 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form BMay 23, 13Mar 11, 14[A61K]
8471012 Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form BAug 31, 11Jun 25, 13[C07D]
8361507 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartanJul 25, 07Jan 29, 13[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7947840 Process for preparation of enantiomerically pure esomeprazoleExpiredSep 25, 07May 24, 11[C07D]
7858812 Process for isolation of desired isomers of nebivolol intermediatesExpiredJan 18, 06Dec 28, 10[C07D]
2010/0197,910 PROCESS FOR PREPARATION OF PRULIFLOXACIN USING NOVEL INTERMEDIATESAbandonedNov 17, 06Aug 05, 10[C07F, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.